Arkolith/Insider Trading/GANX/Form 4/A

Richman Eric I

Chief Executive Officer, DirectorGain Therapeutics, Inc. (GANX) · full profile →Form 4/A · filed Apr 21, 2022
Net Buying
Open-Market Buys
$39K
Open-Market Sells
$0
Net Open-Market Flow
$39K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 16, 2021Buy(P)5K$7.87$39K217K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001209191-22-025180) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML